Back to Search
HONG HUYNH, PHARMD
PHARMD
Pharmacist
NPI: 1447550074Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
17567(NC)
Research & Publications (20)
Sorafenib induces growth suppression in mouse models of gastrointestinal stromal tumor.
PMID 19139124·Mol Cancer Ther·2009
7-preclinical
Sorafenib and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma.
PMID 19220580·J Cell Mol Med·2009
7-preclinical
RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma.
PMID 18466352·J Cell Mol Med·2009
7-preclinical
Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.
PMID 18829493·Clin Cancer Res·2008
7-preclinical
Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma.
PMID 18490075·J Hepatol·2008
7-preclinical
Bevacizumab and rapamycin inhibit tumor growth in peritoneal model of human ovarian cancer.
PMID 18025280·Mol Cancer Ther·2007
7-preclinical
AZD6244 and doxorubicin induce growth suppression and apoptosis in mouse models of hepatocellular carcinoma.
PMID 17876044·Mol Cancer Ther·2007
7-preclinical
Targeted inhibition of the extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) in the treatment of hepatocellular carcinoma.
PMID 17237274·Mol Cancer Ther·2007
7-preclinical
Hemilabile behavior of a thioether-functionalized N-heterocyclic carbene ligand.
PMID 16969473·Chem Commun (Camb)·2006
8-other
Xenografts of human hepatocellular carcinoma: a useful model for testing drugs.
PMID 16857806·Clin Cancer Res·2006
7-preclinical
Extracellular signal-regulated kinase induces cyclin D1 and Cdk-2 expression and phosphorylation of retinoblastoma in hepatocellular carcinoma.
PMID 15547725·Int J Oncol·2004
8-other
2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) inhibits prostate carcinoma cell growth via p53-dependent and p53-independent pathways.
PMID 15529313·Cancer·2004
7-preclinical
Overexpression of tumour suppressor retinoblastoma 2 protein (pRb2/p130) in hepatocellular carcinoma.
PMID 15059924·Carcinogenesis·2004
7-preclinical
Homotypic secretory vesicle fusion induced by the protein tyrosine phosphatase MEG2 depends on polyphosphoinositides in T cells.
PMID 14662869·J Immunol·2003
8-other
Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis.
PMID 12906713·BMC Gastroenterol·2003
7-preclinical
Inhibition of ErbB-2 and ErbB-3 expression by quercetin prevents transforming growth factor alpha (TGF-alpha)- and epidermal growth factor (EGF)-induced human PC-3 prostate cancer cell proliferation.
PMID 12888923·Int J Oncol·2003
8-other
Induction of apoptosis in rat ventral prostate by finasteride is associated with alteration in MAP kinase pathways and Bcl-2 related family of proteins.
PMID 12012013·Int J Oncol·2002
7-preclinical
A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
PMID 11959812·Cell Growth Differ·2002
8-other
Co-administration of finasteride and the pure anti-oestrogen ICI 182,780 act synergistically in modulating the IGF system in rat prostate.
PMID 11572795·J Endocrinol·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 411-C SOUTH MAIN STREET, CVS/PHARMACY
ROLESVILLE, NC 27571 - Phone
- (919) 554-0925
Quick Facts
- NPI
- 1447550074
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile